Abstract. Plasma microRNA (miR)-423-5p is a potential biomarker for the detection of colon cancer. However, the expression and biological role of miR-423-5p in colon tumorigenesis remains unclear. In the current study, reverse transcription-quantitative polymerase chain reaction was used to determine miR-423-5p expression in malignant colon tissues and plasma from patients with colon cancer. Cell viability, colony formation and apoptosis assays, as well as western blotting, were performed to investigate the biological role and regulatory mechanisms of miR-423-5p in colon cancer. The results demonstrated that miR-423-5p expression was downregulated in tumor tissues and plasma from patients with colon cancer, as well as in colon cancer cell lines. Furthermore, overexpression of miR-423-5p promoted colon cancer cell apoptosis and resulted in the inhibition of cell proliferation and colony formation. Mechanistically, miR-423-5p induced the expression of caspases 3, 8 and 9, as well as p53 in colon cancer. The effect of z-VAD treatment indicated that the miR-423-5p-mediated colon cancer cell apoptosis is caspase-dependent. These results suggest that miR-423-5p is a tumor suppressor in colon cancer and a potential diagnostic target to enable the early detection of colon cancer.
Introduction
The mortality rate of patients with colon cancer is one of the highest of all types cancer, due to late tumor presentation and rapid progression (1) . Despite improvements in the diagnosis and treatment of colon cancer, there are ~1,000,000 cases of colon cancer reported annually, with >600,000 mortalities per year (1) . Patients are usually diagnosed when they reach an advanced stage of colon cancer (2) , when surgery is ineffective; however, early stage surgery may be an effective method of attenuating its progression (3) . Therefore, novel prognostic biomarkers and targeted therapeutics are required to enable the early detection and treatment of colon cancer.
MicroRNAs (miRNAs) are a class of endogenous noncoding RNAs 21-23 nucleotides long, which regulate the expression of target genes in mammals either by degrading target mRNA or inhibiting the translation of target genes (4) . A total of 2,042 mature human miRNAs have been identified, which may regulate >30% of target mRNAs (5) . The results of previous studies have demonstrated that miRNAs serve important roles in tumorigenesis by regulating the expression of various oncogenes and tumor suppressor genes (6) (7) (8) . miR-423-5p is an effective serum biomarker for colon cancer. Fang et al (9) demonstrated that the concentration of plasma miR-423-5p was decreased in patients with colon cancer and benign lesions, including polyps and adenoma, compared with healthy controls. Therefore, it has been suggested that plasma levels of miR-423-5p may serve as a biomarker for colon cancer detection, particularly for early stage colon cancer (9) . Indeed, it was demonstrated that in stage I-II colon cancer, serum miR-423-5p was significantly elevated compared with controls, whereas in stage III-IV colon cancer, the differences in miR-423-5p expression between patients with colon cancer and healthy controls were not significant (10) .
However, the expression and function of miR-423-5p in malignant colon tissues and colon cancer tumorigenesis remains unclear. The aim of the present study was to evaluate the expression of miR-423-5p in malignant colon tissues and colon cancer cell lines. The potential regulatory role of miR-423-5p on colon cancer cell proliferation and apoptosis was also determined. These results may provide a novel target for the diagnosis and treatment of colon cancer.
Materials and methods
Clinical samples. The present study was approved by the Ethics Committee of Beijing Hospital (Beijing, China). A total of 25 pairs of diagnostic primary malignant colon samples and adjacent normal colon tissues (used as controls) were obtained from the Department of General Surgery at the Beijing Hospital between May and October 2016. The 25 colon cancer patients, 11 male and 14 female, were between 48 and 78 years (Table I) . Fasting peripheral blood (5 ml) was drawn from each patient and placed in anticoagulative tubes at room temperature for 30 min, followed by centrifugation at 1,500 x g for 5 min at 4˚C. The plasma supernatant was collected and stored at -80˚C until use. Written informed consent was obtained from the patients.
Cell culture. The human colon cancer cell lines HT29, SW480, Caco-2, HCT116 and SW620 were obtained from the American Type Culture Collection (Manassas, VA, USA) and cultured in Dulbecco's modified Eagle's medium (DMEM; Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS; Invitrogen; Thermo Fisher Scientific, Inc.) and antibiotics (penicillin and streptomycin; Invitrogen; Thermo Fisher Scientific, Inc.) at 37˚C in a 100% humid incubator with 5% CO 2 . Normal human colon epithelial cells (HCoEpiC) were purchased from Shanghai Hongshun Biotechnology (Shanghai, China).
Cell transfection. The pU6 vector-based miR-423-5p overexpression plasmid and miR-negative control (NC) expression plasmid were customized and purchased from GenePharma (Shanghai, China). A total of 2 µg miR-423-5p overexpression plasmid or miR-NC were transfected into SW620 and HCT116 cells using 5 µl FuGENE HP ® (Promega Corporation, Madison, WI, USA), following the manufacturer's protocol. A total of 48 h after cell transfection, the cells were collected for further analysis. z-VAD-FMK was purchased from Selleck Chemicals (Shanghai, China) and used to treat cells at a concentration of 50 µM for 24 h following transfection.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Human colon samples and transfected cells were lysed using TRIzol ® reagent (Thermo Fisher Scientific, Inc.) and total RNA was extracted following the manufacturer's protocol. Reverse transcription was performed on the isolated total RNA using a PrimeScript ® RT Master Mix kit (Perfect Real Time; cat. no. RR036A; Takara Bio, Inc., Kusatsu, Japan) and qPCR was performed using a SYBR Green I Real Time PCR kit (cat. no. RR420A; Takara Bio, Inc.), according to the manufacturer's protocol. Reverse transcription was performed at 65˚C for 5 min, 30˚C for 10 min, 42˚C for 10 min and 2˚C for 3 min. qPCR conditions were as follows: Denaturation at 94˚C for 2 min, amplification for 30 cycles at 94˚C for 30 sec, annealing at 59˚C for 30 sec and extension at 72˚C for 1 min, followed by a terminal elongation step at 72˚C for 10 min. The primers for miR-423-5p were purchased from Guangzhou RiboBio Co., Ltd. (cat no. S170721170309; Guangzhou, China). Sequences were not supplied due to the rules of the company. U6 was used as an internal control. qPCR analysis was performed using a Bio-Rad CFX96 thermal cycler (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Data were quantified using the 2 -ΔΔCq method (11, 12) . 1:1,000), caspase 8 (cat. no. 4790; 1:800), caspase 9 (cat. no. 9508; 1:800), p53 (cat. no. 2524; 1:1,000) and GAPDH (cat no. 5174; 1:5,000; all Cell Signaling Technology, Inc., Danvers, MA, USA) at 4˚C overnight. Following washing, membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit (cat. no. TA140003) and mouse secondary antibodies (cat. no. TA140002; both 1:10,000, OriGene Technologies, Inc., Rockville, MD, USA) for 60 min at room temperature. The bands were detected by enhanced chemiluminescent (ECL) kit (Merck KGaA) and the band density were quantified by Image J software (version 1.48; National Institutes of Health, Bethesda, MD, USA). The quantities of samples were normalized based on the expression of GAPDH.
Statistical analysis. All values are expressed as the mean ± standard deviation of ≥3 results. Student's t test and one-way analysis of variance with Dunnett's multiple comparisons test were used to assess differences between groups using SPSS 21.0 (IBM Corp., Armonk, NY, USA). Logistic regression analysis was used to assess the correlation between plasma miR-423-5p expression and tumor grade. P<0.05 was determined to indicate a statistically significant difference.
Results

Downregulation of miR-423-5p in colon cancer tissues and cell lines.
The expression of miR-423-5p in colon cancer tissues and cell lines was investigated using RT-qPCR. miR-423-5p expression was significantly lower in colon tumor tissues (0.55±0.08) compared with normal colon tissues (1.87±0.24; P<0.0001; Fig. 1A ). Logistic regression analysis indicated that miR-423-5p expression was lower in patients with high grade tumors (P<0.05; Fig. 1B ). The expression of miR-423-5p in the plasma of 25 patients with colon cancer compared with healthy controls was also determined. The results indicated that the expression of miR-423-5p in plasma was significantly lower in patients with colon cancer (0.88±0.20) compared with healthy controls (3.85±0.57; P<0.0001; Fig. 1C ). The expression of miR-423-5p in plasma was also decreased as the tumor grade increased (P<0.05; Fig. 1D ). miR-423-5p expression was decreased in malignant colon tissues and plasma from patients with colon cancer; therefore, the expression of miR-423-5p was subsequently assessed in colon cancer cell lines. The results indicated that it was significantly downregulated in all colon cancer cell lines compared with HCoEpiCs (all P<0.01; Fig. 1E ). These results suggest that the expression of miR-423-5p is downregulated in colon cancer and decreases as tumor grade increases.
Overexpression of miR-423-5p inhibits colon cancer growth and colony formation. miR-423-5p was cloned into a plasmid expression system and transfected into cells to validate its effects on colon cancer. miR-423-5p transfection significantly upregulated miR-423-5p levels in SW620 and HCT116 cells (Fig. 2A) . The results of the CCK8 assay indicated that the overexpression of miR-423-5p in SW620 and HCT116 cells significantly reduced cell viability by 42.5 and 46.6%, respectively, compared with that of the miR-NC-transfected groups at 72 h (n=4; P<0.01; Fig. 2B ). Colony formation was also significantly decreased in HCT116 (87.3±11.3 vs. 13.7±3.7, miR-NC vs. miR-423-5p) and SW620 (93.3±10.6 vs. 22.3±5.9, miR-NC vs. miR-423-5p) cells transfected with miR-423-5p (both P<0.01; Fig. 2C ). These results suggest that the overexpression of miR-423-5p inhibits colon cancer cell proliferation and colony formation.
Overexpression of miR-423-5p promotes apoptosis and caspase protein expression in colon cancer cells.
The mechanism underlying the miR-423-5p-mediated inhibition of colon cancer cell growth was determined using flow cytometry in SW620 and HCT116 cells following transfection with miR-423-5p and miR-NC. The results indicated that the rate of apoptosis was increased in SW620 (2.9±0.9% vs. 10.6±1.1%, miR-NC vs. miR-423-5p) and HCT116 (3.8±0.5% vs. 13.8±1.6%, miR-NC vs. miR-423-5p) cells following miR-423-5p transfection (both P<0.01; Fig. 3A) . Furthermore, the expression of caspases 3, 8 and 9 in miR-NC and SW620 and HCT116 cells transfected with miR-423-5p was measured using western blotting. The expression of caspases 3, 8, 9 and p53 were increased in SW620 and HCT116 cells transfected with miR-423-5p compared with the respective cells transfected with miR-NC (all P<0.01; Fig. 3B ). These results suggest that the overexpression of miR-423-5p promotes apoptosis and the expression of caspases in colon cancer cells.
miR-423-5p induces caspase-dependent apoptosis in colon cancer cells. z-VAD is an inhibitor of caspase activity and was used to treat miR-423-5p-transfected colon cancer cells. z-VAD treatment attenuated the miR-423-5p-mediated upregulation of apoptosis in SW620 cells (11.5±1.5% vs. 4.5±0.9%, miR-423-5p vs. miR-423-5p+z-VAD; P<0.05) and HCT116 cells (14.9±0.9% vs. 5.8±0.5%, miR-423-5p vs. miR-423-5p+z-VAD; P<0.01; Fig. 4 ). There were no significant differences in the rates of apoptosis between the miR-NC-transfected and miR-423-5p+z-VAD groups in SW620 cells (2.9±0.7% vs. 4.5±0.9%, miR-NC vs. miR-423-5p+z-VAD) and HCT116 cells (3.9±0.6% vs. 5.8±0.5%, miR-NC vs. miR-423-5p+z-VAD). These results indicate that miR-423-5p induces caspase-dependent apoptosis in colon cancer cells.
Discussion
The results of the current study demonstrated that miR-423-5p expression was significantly downregulated in colon malignant tissues, as well as in colon cancer cell lines. It was demonstrated that miR-423-5p inhibits colon cancer cell proliferation and colony formation, thereby promoting cell apoptosis. Furthermore, the effects of z-VAD demonstrated that miR-423-5p-mediated colon cancer cell apoptosis is caspase-dependent. These results suggest that miR-423-5p is downregulated in colon cancer and functions as a tumor suppressor.
miR-423-5p is upregulated in the myocardium following heart failure and is associated with the prohormone brain natriuretic peptide and ejection fraction (13) . However, it is not an effective biomarker of systemic ventricular and left ventricular remodeling (14, 15) . Furthermore, it has been demonstrated that miR-423-5p significantly downregulates the expression of β-linked N-acetylglucosamine transferase and its associated downstream targets, and also induces apoptosis in cardiomyocytes (16) . Furthermore, miR-423-5p expression is increased in the serum of patients with hepatocarinoma following treatment with sorafenib and miR-423-5p promotes autophagy (17) . It has been determined that miR-423-5p knockdown enhances the sensitivity of glioma stem cells to apigenin via the mitochondrial pathway (18) . In addition, plasma miR-423-5p may be a biomarker for colon cancer (9, 10) . The current study demonstrated that miR-423-5p is downregulated in colon malignant tissues and colon cancer cell lines. Overexpression of miR-423-5p impaired colon cancer cell proliferation and colony formation in vitro. These results improve understanding of the role miR-423-5p serves in colon cancer.
Environmental factors and accumulation of mutations serve a role in the development of colon cancer, resulting in increased cell proliferation, uncontrolled angiogenesis, inhibition of apoptosis and immune system evasion (19) (20) (21) (22) . Evasion of apoptosis is one of the hallmarks of human cancer (23) . Damaged or unnecessary cells are normally eliminated by apoptosis via the extrinsic and intrinsic apoptotic pathways (23) . Thus, promoting the apoptosis of tumor cells may be an effective method of treating colon cancer. Agents that induce cellular DNA damage and cause cell apoptosis, including irinotecan and cisplatin, are commonly used to treat patients with colon cancer (24, 25) . In the current study, the role of miR-423-5p in promoting cell apoptosis and caspase expression in colon cancer was determined. The results indicated that miR-423-5p-mediated cell apoptosis is caspase-dependent, thus improving the understanding of the mechanisms by which miR-423-5p regulates apoptosis.
In conclusion, the results of the current study demonstrated that miR-423-5p is downregulated in colon malignant tissues and colon cancer cell lines. Overexpression of miR-423-5p induces caspase-dependent apoptosis, resulting in inhibition of cell proliferation and colony formation. Taken together, the results of the current study suggest that miR-423-5p may serve be an effective target for the detection and treatment of colon cancer.
